Clinical Trial Update: Neoadjuvant Intra-tumoral RP2 and FLOT in Gastroesophageal Adenocarcinoma [Phase 2]

View source ↗

Summary

A Phase 2 neoadjuvant trial evaluating intra-tumoral RP2 in combination with the FLOT regimen for gastric and esophageal adenocarcinoma is listed as not yet rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Adenocarcinoma
• Gastric Adenocarcinoma
• Gastroesophageal Junction Adenocarcinoma

Drugs mentioned

• FLOT regimen (Fluorouracil, Leucovorin, Oxaliplatin, Docetaxel)
• RP2

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Gastric Adenocarcinoma, Esophageal Adenocarcinoma | Phase 2 | Status: NOT_YET_RECRUITING